Clinical Trials on Relapsed or Refractory Lymphoproliferative Malignancies
Total 5415 results
-
University of Maryland, BaltimoreActive, not recruitingRelapsed or Refractory Acute Myeloid LeukemiaUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Large B-cell LymphomaUnited States, Australia, Canada
-
Allogene TherapeuticsRecruitingRelapsed/Refractory Large B Cell LymphomaBelgium, United States, Austria
-
Stanford UniversityMerck Sharp & Dohme LLCRecruitingHodgkin Lymphoma | Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Relapsed Classical Hodgkin LymphomaUnited States
-
Kronos BioRecruitingNon-Hodgkin Lymphoma | Refractory Solid Tumors | Relapsed Solid TumorsUnited States, Spain, United Kingdom
-
French Innovative Leukemia OrganisationBristol-Myers SquibbCompletedSmall Lymphocytic Leukemia | CLL, Relapsed | CLL, Refractory | Bruton Tyrosine Kinase InhibitorFrance
-
Institute of Hematology & Blood Diseases Hospital...YL-PharmaActive, not recruitingRelapsed/Refractory Large Granular T Lymphocytic LeukemiaChina
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
SIRPant Immunotherapeutics, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Fate TherapeuticsRecruitingRelapsed/Refractory B-Cell LymphomaUnited States
-
Chinese PLA General HospitalRecruitingStudy of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid TumorsAdvanced Solid Tumors | Relapsed/Refractory Non-Hodgkin LymphomaChina
-
UNC Lineberger Comprehensive Cancer CenterAmerican Society of Clinical OncologyRecruitingRefractory Hodgkin Lymphoma | Relapsed Hodgkin LymphomaUnited States
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory Mantle Cell LymphomaUnited States, France, Spain, United Kingdom, Netherlands, Germany
-
La Raza Medical CenterCompletedRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaMexico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene Corporation; Biologics...CompletedRelapsed/Refractory Mantle Cell LymphomaUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownRelapsed / Refractory Mantle Cell Lymphoma (MCL)China
-
Nantes University HospitalCompletedHaemato-lymphoid Malignancies or Syndromes in Whom Allogeneic Stem Cell Transplantation is WarrantedFrance
-
Assistance Publique Hopitaux De MarseilleRecruitingCancer and / or Hematological MalignancyFrance
-
Lixia ShengNot yet recruitingOR Regimen Refractory Marginal Zone Lymphoma
-
Charite University, Berlin, GermanyPfizerUnknownRecurrent or Refractory Primary CNS LymphomaGermany
-
AmgenMerck Sharp & Dohme LLCTerminatedRelapsed or Refractory Acute Myeloid LeukemiaUnited States
-
OncoTherapy Science, Inc.TerminatedRelapsed or Refractory Synovial SarcomaJapan
-
Chinese PLA General HospitalUnknownRefractory or Relapsed Aggressive r/r B-NHL With Huge Tumor BurdenChina
-
Second Affiliated Hospital, School of Medicine,...Active, not recruitingPrimary Central Nervous System Lymphoma | Refractory Central Nervous System Lymphoma | Relapsed Primary Central Nervous System LymphomaChina
-
Henan Cancer HospitalHenan Hualong Biotechnology CompanyUnknownRefractory | B-Cell Lymphoma Stage I | RelapsedChina
-
Genta IncorporatedCompletedNon-Hodgkin's Lymphoma | Refractory Lymphoma | Relapsed Lymphoma | Low-Grade Lymphoma | Intermediate-Grade LymphomaUnited States
-
Institute of Hematology & Blood Diseases Hospital...YL-PharmaRecruitingRelapsed/Refractory Large Granular T Lymphocytic LeukemiaChina
-
Cellular Biomedicine Group Ltd.RecruitingRelapsed/Refractory Large B-Cell LymphomaChina
-
Second Affiliated Hospital, School of Medicine,...RecruitingRelapsed and Refractory B-cell LymphomaChina
-
Kite, A Gilead CompanyHumanigen, Inc.TerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
Kite, A Gilead CompanyPfizerTerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
Nantes University HospitalTerminatedRelapsed/Refractory LeukemiaFrance
-
Institut BergoniéMinistry of Health, France; PharmaMarTerminatedAdult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated LiposarcomaFrance
-
Memorial Sloan Kettering Cancer CenterWithdrawnEBV Lymphomas | EBV-associated Malignancies
-
Vanderbilt-Ingram Cancer CenterHuman Animal Bond Research InstituteCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
Scripps Translational Science InstituteCompleted
-
AstraZenecaWithdrawnCore: Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
-
CytoMed Therapeutics Pte LtdNational University Hospital, SingaporeNot yet recruitingCancer | Malignancy | Relapsed Cancer | Refractory CancerSingapore
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
CARGO TherapeuticsRecruitingCancer | Relapsed/Refractory Large B-cell Lymphoma (LBCL)United States
-
Tarapeutics Science Inc.RecruitingAdvanced Solid Tumor | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryChina
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
National Cancer Institute (NCI)RecruitingAcute Lymphoblastic Leukemia | Relapsed/Refractory | B CellUnited States
-
Fundacion Clinic per a la Recerca BiomédicaNot yet recruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaSpain
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, China, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina, Puerto Rico
-
Chongqing Precision Biotech Co., LtdRecruitingNon Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaChina
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Aggressive B-Cell LymphomaUnited States, Germany, Spain
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
AHS Cancer Control AlbertaTom Baker Cancer CentreTerminatedFollicular Lymphoma | Hodgkin's Lymphoma - Relapsed/Refractory | Non-Hodgkin's Lymphoma - AggressiveCanada
-
BeiGeneCompletedRefractory Mantle Cell Lymphoma | Relapsed Mantle Cell LymphomaChina